Prenetics Global Limited (PRE)
3.71
0.11 (3.06%)
At close: Apr 14, 2025, 3:49 PM
3.54
-4.51%
After-hours: Apr 14, 2025, 06:00 PM EDT
3.06% (1D)
Bid | 3.47 |
Market Cap | 45.33M |
Revenue (ttm) | 25.56M |
Net Income (ttm) | -49.01M |
EPS (ttm) | -3.73 |
PE Ratio (ttm) | -0.99 |
Forward PE | -9.46 |
Analyst | Buy |
Ask | 3.85 |
Volume | 10,252 |
Avg. Volume (20D) | 11,632 |
Open | 3.84 |
Previous Close | 3.60 |
Day's Range | 3.55 - 3.84 |
52-Week Range | 2.85 - 7.84 |
Beta | -0.21 |
About PRE
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jul 16, 2021
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRE
Website https://www.prenetics.com
Analyst Forecast
According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 142.59% from the latest price.
Stock Forecasts6 months ago
+19.13%
Prenetics Global shares are trading higher followi...
Unlock content with
Pro Subscription
7 months ago
+5.47%
Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.

2 years ago · fool.com
Why Prenetics Global Stock Is Skyrocketing TodayThe company announced a key FDA clearance.